BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1302582)

  • 1. Molecular pathogenesis of chronic myelogenous leukaemia.
    Ankathil R; Nair MK
    Natl Med J India; 1992; 5(5):219-22. PubMed ID: 1302582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular biology of chronic myeloid leukemia].
    Hellmann A
    Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into the Philadelphia translocation.
    Heisterkamp N; Groffen J
    Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
    Usui N
    Rinsho Byori; 2004 Feb; 52(2):136-44. PubMed ID: 15027317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myelogenous leukemia as a model for the genetic basis of cancer.
    Cannistra SA
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):337-57. PubMed ID: 2182595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the hybrid P210 bcr/abl protein in Philadelphia chromosome positive B-lymphoid cell lines.
    Stacchini A; Ponzetto C; Guerrasio A; Martinotti G; Rege Cambrin G; Scaravaglio P; Rosso C; Piacibello W; Aglietta M; Saglio G
    Haematologica; 1989; 74(3):249-54. PubMed ID: 2511093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
    Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
    Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myelogenous leukemia as gene activation model in oncology minireview.
    Zámecníková A
    Neoplasma; 2000; 47(5):269-73. PubMed ID: 11130241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
    Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
    Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
    Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
    Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV
    Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
    Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
    Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
    Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
    J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal translocations in leukaemia.
    Gauwerky CE; Croce CM
    Semin Cancer Biol; 1993 Dec; 4(6):333-40. PubMed ID: 8142618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.